Cargando…
Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations
This article reviews the current knowledges of congenital bleeding disorders (CBD) amid the COVID-19 pandemic. It appears that CBD is not associated with higher risk of getting COVID-19 and so the prevalence of COVID-19 among them seems not higher compared to the general population. In absence of sp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716957/ https://www.ncbi.nlm.nih.gov/pubmed/32921723 http://dx.doi.org/10.23750/abm.v91i3.10203 |
_version_ | 1783619261859627008 |
---|---|
author | Naderi, Majid Malek, Fatemeh Miri Aliabad, Ghasem Behnampoor, Mahammad de Sanctis, Vincenzo Karimi, Mehran |
author_facet | Naderi, Majid Malek, Fatemeh Miri Aliabad, Ghasem Behnampoor, Mahammad de Sanctis, Vincenzo Karimi, Mehran |
author_sort | Naderi, Majid |
collection | PubMed |
description | This article reviews the current knowledges of congenital bleeding disorders (CBD) amid the COVID-19 pandemic. It appears that CBD is not associated with higher risk of getting COVID-19 and so the prevalence of COVID-19 among them seems not higher compared to the general population. In absence of specific therapeutic recommendations, it is essential to make a correct assessment of the risk of haemorrhage/thrombosis. Based on expert opinion, strategies for outpatient management include adherence to prescribed regimens, telemedicine, and communication about COVID-19 in patients with CBD. More data should be also collected to better characterize the impact of COVID-19 on patients with CBD. The current findings encourage further studies to determine the prevalence of SARS-CoV2 infection in CBD patients to understand more fully the burden of this novel pathogen and to develop adequate preventive measures against this infection. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-7716957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-77169572020-12-07 Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations Naderi, Majid Malek, Fatemeh Miri Aliabad, Ghasem Behnampoor, Mahammad de Sanctis, Vincenzo Karimi, Mehran Acta Biomed Reviews / Focus on This article reviews the current knowledges of congenital bleeding disorders (CBD) amid the COVID-19 pandemic. It appears that CBD is not associated with higher risk of getting COVID-19 and so the prevalence of COVID-19 among them seems not higher compared to the general population. In absence of specific therapeutic recommendations, it is essential to make a correct assessment of the risk of haemorrhage/thrombosis. Based on expert opinion, strategies for outpatient management include adherence to prescribed regimens, telemedicine, and communication about COVID-19 in patients with CBD. More data should be also collected to better characterize the impact of COVID-19 on patients with CBD. The current findings encourage further studies to determine the prevalence of SARS-CoV2 infection in CBD patients to understand more fully the burden of this novel pathogen and to develop adequate preventive measures against this infection. (www.actabiomedica.it) Mattioli 1885 2020 2020-09-07 /pmc/articles/PMC7716957/ /pubmed/32921723 http://dx.doi.org/10.23750/abm.v91i3.10203 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Reviews / Focus on Naderi, Majid Malek, Fatemeh Miri Aliabad, Ghasem Behnampoor, Mahammad de Sanctis, Vincenzo Karimi, Mehran Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations |
title | Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations |
title_full | Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations |
title_fullStr | Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations |
title_full_unstemmed | Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations |
title_short | Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations |
title_sort | congenital bleeding disorders amid the covid-19 pandemic: open questions and recommendations |
topic | Reviews / Focus on |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716957/ https://www.ncbi.nlm.nih.gov/pubmed/32921723 http://dx.doi.org/10.23750/abm.v91i3.10203 |
work_keys_str_mv | AT naderimajid congenitalbleedingdisordersamidthecovid19pandemicopenquestionsandrecommendations AT malekfatemeh congenitalbleedingdisordersamidthecovid19pandemicopenquestionsandrecommendations AT mirialiabadghasem congenitalbleedingdisordersamidthecovid19pandemicopenquestionsandrecommendations AT behnampoormahammad congenitalbleedingdisordersamidthecovid19pandemicopenquestionsandrecommendations AT desanctisvincenzo congenitalbleedingdisordersamidthecovid19pandemicopenquestionsandrecommendations AT karimimehran congenitalbleedingdisordersamidthecovid19pandemicopenquestionsandrecommendations |